X
Record #47374

A deep insight into CAR-T cell therapy in non-Hodgkin lymphoma: application, opportunities, and future directions

Publisher
Frontiers
Original paper date
Jun 23, 2021
Institution
Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran · Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran · College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq · Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaimaniyah, Iraq · Department of Pediatric Dentistry, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia · Department of Economics and Industrial Engineering, St. Petersburg University of Management and Economics, St. Petersburg, Russia · Department of Postgraduate and Doctoral Studies, Russian New University, Moscow, Russia · Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand · Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia · Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt · Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russia · Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States · Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran · Taneja College of Pharmacy, University of South Florida, Tampa, FL, United States · Department of Pharmaceutical Science, Faculty of Pharmacy, Airlangga University, Subaraya, Indonesia · German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), Heidelberg, Germany
Open access
No
Article type
Review Article
Broad categories
(BLS) Biology - Cancer(BLS) Biology - Cellular(HSC) Medicine - Oncology(HSC) Medicine - Rehabilitation/Therapy
Notes from Retraction Watch

see also: https://blog.frontiersin.org/2023/09/04/frontiers-implements-new-policy-to-counter-authorship-for-sale/

Citation lifecycle

How this paper is being cited

Pre-retraction
21
Same day
0
Post-retraction
22
% post-retraction
51.2%
~9.6 citations/yr before retraction · ~7.2 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse